{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:49:46Z","timestamp":1785437386826,"version":"3.56.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>ATP2B1<\/jats:italic> encodes plasma membrane calcium-transporting-ATPase1 and plays an essential role in maintaining intracellular calcium homeostasis that regulates diverse signaling pathways. Heterozygous de novo missense and truncating <jats:italic>ATP2B1<\/jats:italic> variants are associated with a neurodevelopmental phenotype of variable expressivity. We describe a proband with distinctive craniofacial gestalt, Pierre-Robin sequence, neurodevelopmental and growth deficit, periventricular heterotopia, brachymesophalangy, cutaneous syndactyly, and persistent hypocalcemia from primary hypoparathyroidism. Proband-parent trio exome sequencing identified compound heterozygous <jats:italic>ATP2B1<\/jats:italic> variants: a maternally inherited splice-site (c.3060+2\u2009T\u2009&gt;\u2009G) and paternally inherited missense c.2938\u2009G\u2009&gt;\u2009T; p.(Val980Leu). Reverse-transcription-PCR on the proband\u2019s fibroblast-derived mRNA showed aberrantly spliced <jats:italic>ATP2B1<\/jats:italic> transcripts targeted for nonsense-mediated decay. All correctly-spliced <jats:italic>ATP2B1<\/jats:italic> mRNA encoding p.(Val980Leu) functionally causes decreased cellular Ca<jats:sup>2+<\/jats:sup> extrusion. Immunoblotting showed reduced fibroblast ATP2B1. We conclude that biallelic <jats:italic>ATP2B1<\/jats:italic> variants are the likely cause of the proband\u2019s phenotype, strengthening the association of <jats:italic>ATP2B1<\/jats:italic> as a neurodevelopmental gene and expanding the phenotypic characterization of a biallelic loss-of-function genotype.<\/jats:p>","DOI":"10.1038\/s41431-023-01484-9","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T03:01:33Z","timestamp":1699239693000},"page":"125-129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Biallelic ATP2B1 variants as a likely cause of a novel neurodevelopmental malformation syndrome with primary hypoparathyroidism"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4372-0580","authenticated-orcid":false,"given":"Patrick","family":"Yap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa G.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purvi M.","family":"Kakadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2202-9088","authenticated-orcid":false,"given":"Stefan K.","family":"Bohlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3396-9611","authenticated-orcid":false,"given":"Meer Jacob","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salam","family":"Alburaiky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Oppermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristin","family":"Print","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7314-5097","authenticated-orcid":false,"given":"Sandra T.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9436-5857","authenticated-orcid":false,"given":"Polona","family":"Le Quesne Stabej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,6]]},"reference":[{"key":"1484_CR1","first-page":"190","volume":"16","author":"EE Strehler","year":"2013","unstructured":"Strehler EE. Plasma membrane calcium ATPases as novel candidates for therapeutic agent development. J Pharm Pharm Sci a Publ Can Soc Pharm Sci Soc Can des Sci Pharm. 2013;16:190\u2013206.","journal-title":"J Pharm Pharm Sci a Publ Can Soc Pharm Sci Soc Can des Sci Pharm"},{"key":"1484_CR2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/1284","volume":"19","author":"VA Street","year":"1998","unstructured":"Street VA, McKee-Johnson JW, Fonseca RC, Tempel BL, Noben-Trauth K. Mutations in a plasma membrane Ca2+-ATPase gene cause deafness in deafwaddler mice. Nat Genet. 1998;19:390\u20134.","journal-title":"Nat Genet"},{"key":"1484_CR3","doi-asserted-by":"publisher","first-page":"a035113","DOI":"10.1101\/cshperspect.a035113","volume":"12","author":"J Chen","year":"2020","unstructured":"Chen J, Sitsel A, Benoy V, Sep\u00falveda MR, Vangheluwe P. Primary active Ca(2+) transport systems in health and disease. Cold Spring Harb Perspect Biol. 2020;12:a035113.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1484_CR4","doi-asserted-by":"publisher","first-page":"33742","DOI":"10.1074\/jbc.M404628200","volume":"279","author":"GW Okunade","year":"2004","unstructured":"Okunade GW, Miller ML, Pyne GJ, Sutliff RL, O\u2019Connor KT, Neumann JC, et al. Targeted ablation of plasma membrane Ca2+-ATPase (PMCA) 1 and 4 indicates a major housekeeping function for PMCA1 and a critical role in hyperactivated sperm motility and male fertility for PMCA4. J Biol Chem. 2004;279:33742\u201350.","journal-title":"J Biol Chem"},{"key":"1484_CR5","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nature19356","volume":"537","author":"ME Dickinson","year":"2016","unstructured":"Dickinson ME, Flenniken AM, Ji X, Teboul L, Wong MD, White JK, et al. High-throughput discovery of novel developmental phenotypes. Nature 2016;537:508\u201314.","journal-title":"Nature"},{"key":"1484_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41440-018-0067-8","volume":"41","author":"Y Ehara","year":"2018","unstructured":"Ehara Y, Hirawa N, Sumida K, Fujiwara A, Kagimoto M, Ooki-Okuyama Y, et al. Reduced secretion of parathyroid hormone and hypocalcemia in systemic heterozygous ATP2B1-null hypertensive mice. Hypertens Res. 2018;41:699\u2013707.","journal-title":"Hypertens Res"},{"key":"1484_CR7","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3390\/cells9081800","volume":"9","author":"A Bouron","year":"2020","unstructured":"Bouron A. Transcriptomic profiling of Ca2+ transport systems during the formation of the cerebral cortex in mice. Cells 2020;9:1800.","journal-title":"Cells"},{"key":"1484_CR8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/ng.384","volume":"41","author":"D Levy","year":"2009","unstructured":"Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677\u201387.","journal-title":"Nat Genet"},{"key":"1484_CR9","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1161\/HYPERTENSIONAHA.110.165068","volume":"59","author":"Y Kobayashi","year":"2012","unstructured":"Kobayashi Y, Hirawa N, Tabara Y, Muraoka H, Fujita M, Miyazaki N, et al. Mice lacking hypertension candidate gene ATP2B1 in vascular smooth muscle cells show significant blood pressure elevation. Hypertension 2012;59:854\u201360.","journal-title":"Hypertension"},{"key":"1484_CR10","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.ajhg.2022.03.009","volume":"109","author":"MJ Rahimi","year":"2022","unstructured":"Rahimi MJ, Urban N, Wegler M, Sticht H, Schaefer M, Popp B, et al. De novo variants in ATP2B1 lead to neurodevelopmental delay. Am J Hum Genet. 2022;109:944\u201352.","journal-title":"Am J Hum Genet"},{"key":"1484_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41525-019-0081-z","volume":"4","author":"R Dawes","year":"2019","unstructured":"Dawes R, Lek M, Cooper ST. Gene discovery informatics toolkit defines candidate genes for unexplained infertility and prenatal or infantile mortality. NPJ Genom Med. 2019;4:8.","journal-title":"NPJ Genom Med"},{"key":"1484_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fcell.2018.00005","volume":"6","author":"M Chen","year":"2018","unstructured":"Chen M, Laursen SH, Habekost M, Knudsen CH, Buchholdt SH, Huang J, et al. Central and peripheral nervous system progenitors derived from human pluripotent stem cells reveal a unique temporal and cell-type specific expression of PMCAs. Front Cell Dev Biol. 2018;6:5.","journal-title":"Front Cell Dev Biol"},{"key":"1484_CR13","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/humu.22844","volume":"36","author":"N Sobreira","year":"2015","unstructured":"Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat. 2015;36:928\u201330.","journal-title":"Hum Mutat"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01484-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01484-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01484-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:05:17Z","timestamp":1704672317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01484-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,6]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1484"],"URL":"https:\/\/doi.org\/10.1038\/s41431-023-01484-9","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,6]]},"assertion":[{"value":"2 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"STC is director of Frontier Genomics Pty Ltd (Australia). STC currently receives no consultancy fees or other remuneration for this role. Frontier Genomics Pty Ltd (Australia) has no existing financial relationships that will benefit from publication of these data. All other contributing authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The family was enrolled in a research-based proband-parent trio exome sequencing project for undiagnosed rare syndromes (approved by the Health and Disability Ethics Committee of New Zealand HDEC 18\/CEN\/62). Written informed consent for publication of images was obtained from the study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}